Stockreport

Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative [Read more]